Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Gross Margin
Dongkook Pharmaceutical Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
KR |
D
|
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
|
661.7B KRW |
55%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
714.8B USD |
81%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
56%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
371.5B USD |
69%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK |
85%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
200.7B CHF |
73%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
179.7B CHF |
75%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
160B GBP |
82%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
200.5B USD |
81%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
162.4B USD |
68%
|
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
114.6B EUR |
70%
|
Dongkook Pharmaceutical Co Ltd
Glance View
DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2007-05-29. The firm develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. The company also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The firm distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Dongkook Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 55.2%.